ライフサイエンスコーパス: semiannual

1 and 24 months; 3) IVM+ALB annual; 4) IVM+ALB semiannual.

2 Screening of HBsAg carriers with semiannual AFP was effective in detecting most HCC tumor

3 Surveillance receipt was classified as semiannual, annual, or no surveillance.

4 In a community oral health program, semiannual application of FV resulted in caries preventi

5 one-quarter mile or climbing 10 steps during semiannual assessments over 13 y.

6 symptomatic depression or anxiety over nine semiannual assessments was found, despite substantial HI

7 ) IVM annual at 0, 12, and 24 months; 2) IVM semiannual at 0, 6, 12, 18 and 24 months; 3) IVM+ALB ann

8 Analyses of semiannual blood samples obtained from six infected men

9 jectories, demonstrate that (i) seasonal and semiannual climatic changes were highly influential in s

10 ized 2:1 to (1) 6-month PrEP dispensing with semiannual clinic visits and interim HIVST at 3 months o

11 HIV-positive adults were seen at semiannual clinic visits, at which time weight, fat, and

12 Subjects underwent extensive semiannual clinical, psychiatric, neuropsychological, an

13 semiannual Papanicolaou smear screening, and semiannual colposcopy exceeded $375,000 per QALY saved.

14 Papanicolaou smears, annual colposcopy, and semiannual colposcopy--were considered.

15 dence and risk behavior, ascertained through semiannual confidential interviews, between 1988 and 199

16 IDUs were enrolled in 23 semiannual cross-sections from three community sites.

17 amplitude and peak timing of the annual and semiannual cycles were estimated.

18 Semiannual determinations of early preintrusive atherosc

19 eive either 3 annual doses of IA (N = 52), 6 semiannual doses of ALB 400 mg (N = 45), or 6 semiannual

20 emiannual doses of ALB 400 mg (N = 45), or 6 semiannual doses of ALB 800 mg (N = 47).

21 al hip, and femoral neck were measured using semiannual dual-energy x-ray absorptiometry at enrolment

22 cribe the amplitude and timing of annual and semiannual epidemic cycles, and the resulting seasonal p

23 A compliant semiannual examination was defined as an examination wit

24 percent body fat were measured at annual or semiannual examinations through 2015 (n = 1,017).

25 As part of a longitudinal study with semiannual examinations, 268 women in Baltimore, Marylan

26 by annual oral-glucose-tolerance testing and semiannual fasting plasma glucose measurement.

27 men enrolled in a large cohort that entailed semiannual follow-up (initiated in 1994).

28 d and level of copy-years viremia over 2,281 semiannual follow-up assessments were 29,628 copies/mL (

29 ged 35-60 years were enrolled into a 2-year, semiannual follow-up study.

30 cruited from 6 US cities who participated in semiannual follow-up visits in the Women's Interagency H

31 n whom metastasis developed while undergoing semiannual follow-up with LFTs, including aspartate-amin

32 The subjects underwent semiannual follow-ups during the study period.

33 At the 5 semiannual followup visits, the mean TIINE concentration

34 , IVM semiannual, IVM+ALB annual and IVM+ALB semiannual groups respectively (p=0.1229).

35 IVM semiannual, IVM+ALB annual, and IVM+ALB semiannual groups, respectively (P = .1229).

36 York City area were evaluated at two or more semiannual gynecologic examinations that included a Pap

37 Semiannual HCC surveillance was significantly associated

38 Semiannual influenza vaccination in older residents of t

39 Results suggest that a semiannual interval is preferable for ipsilateral mammog

40 Recurrences identified at semiannual intervals were significantly less advanced th

41 Outcome events were probed during semiannual interviews and verified by medical record rev

42 n participating in a longitudinal study with semiannual interviews over 3 years.

43 after IVM+ALB annual, and 43/53 (81%) after semiannual IVM+ALB.

44 after annual IVM+ALB, and 43/53 (81%) after semiannual IVM+ALB.

45 56 (63%) after annual IVM, 42/59 (71%) after semiannual IVM, 39/64 (61%) after annual IVM+ALB, and 43

46 56 (63%) after annual IVM, 42/59 (71%) after semiannual IVM, 39/64 (61%) after IVM+ALB annual, and 43

47 normal embryogenesis in the IVM annual, IVM semiannual, IVM+ALB annual and IVM+ALB semiannual groups

48 normal embryogenesis in the IVM annual, IVM semiannual, IVM+ALB annual, and IVM+ALB semiannual group

49 for the surveillance of HCC are based on the semiannual liver ultrasound (with or without serum alpha

50 tutional post-BCT protocol, which recommends semiannual mammographic examinations of the ipsilateral

51 ic of the Congo demonstrated the efficacy of semiannual mass drug administration (MDA) with albendazo

52 d, with a median of 10 years of quarterly or semiannual monitoring data per site including more than

53 At each semiannual or annual visit, cervical specimens were scre

54 d in north China, whereas southern China had semiannual outbreaks in May and September-October.

55 Semiannual Papanicolaou smear screening provided a furth

56 ditional benefit compared with that given by semiannual Papanicolaou smear screening, and semiannual

57 Centers for Disease Control and Prevention), semiannual Papanicolaou smears, annual colposcopy, and s

58 D symptoms and impairment were assessed with semiannual parent and teacher reports using the ADHD Rat

59 This drives semiannual patterns of seasonal transmission rates that

60 12.3-20.4) in July to December 2021 (average semiannual percentage changes, 15.9; 95% CI, 8.7-23.6; P

61 sness in San Francisco were assessed through semiannual point-in-time counts.

62 We aimed to establish the efficiency of semiannual PrEP clinic visits supplemented with interim

63 sis of secondary trial end points at 1 year, semiannual PrEP dispensing with interim HIVST resulted i

64 of 577 of 2884 radiology residents who took semiannual progress tests during 5 years were retrospect

65 study of long-term outcomes of RA completed semiannual questionnaires from 1998 through 2005, during

66 inal study of outcome in RA completed 25,050 semiannual questionnaires from January 1999 through Dece

67 al structural left-censored linear model for semiannual repeated assessments of viral load showed a 1

68 The ACS NSQIP January 2013 Semiannual Report provided risk-adjusted hospital qualit

69 ting sites were studied during 9 consecutive semiannual reporting periods (2010-2014).

70 Masked, confidential semiannual reports are then distributed to each program'

71 in the NSQIP were obtained through review of semiannual reports published by the ACS.

72 As a result of a semiannual review by the Children's Oncology Group Data

73 g in women 15 to 29 years of age followed by semiannual screening for those with a history of infecti

74 g in women 15 to 29 years of age followed by semiannual screening for those with a history of infecti

75 nd 4) annual screening followed by selective semiannual screening for women with a history of infecti

76 ing of those with a history of infection for semiannual screening is very cost-effective compared wit

77 Semiannual screening visits included blood sampling and

78 t treatments for AKs on the face and ears at semiannual study visits and in between study visits was

79 .0% (5.3%-33.3%) of patients having received semiannual surveillance and 22.3% (14.3%-28.8%) of patie

80 Semiannual surveillance was associated with hepatitis B

81 was used to identify factors associated with semiannual surveillance.

82 16.1 (standard deviation, 0.4) years) with 9 semiannual survey waves, we used Markov multistate trans

83 Semiannual surveys of all participants (N = 2228) identi

84 Secondary data included semiannual surveys of all participants.

85 Baseline and annual or semiannual systemic and laboratory evaluations were perf

86 ing 2 reliable tests at baseline followed by semiannual testing and confirmation of progression throu

87 V testing, our analysis identifies PrEP with semiannual testing as the cost-effective HIV prevention

88 However, semiannual treatment was superior to annual treatment fo

89 However, semiannual treatment was superior to annual treatment fo

90 Repeated semiannual treatment with ALB is macrofilaricidal for W.

91 mpared the efficacy and safety of 3 years of semiannual treatment with ALB to annual IA in persons wi

92 as undertaken to determine whether annual or semiannual treatment with ivermectin (IVM; 200 ug/kg) pl

93 as undertaken to determine whether annual or semiannual treatment with ivermectin (IVM; 200ug/kg) plu

94 5% confidence interval [CI] 8.6-33.4) in the semiannual vaccination group.

95 Semiannual vaccination significantly increased GMTs agai

96 Nonsignificant findings associated with semiannual versus annual intervals included smaller tumo

97 were compared to concurrent (within +/- one semiannual visit) neuropsychological testing performance

98 protein-to-creatinine ratio was measured at semiannual visits among men in the Multicenter AIDS Coho

99 End-stage liver disease was assessed at semiannual visits and by review of medical records and d

100 Semiannual visits at 6 clinical sites included Pap testi

101 serum HCV RNA concentrations varied between semiannual visits by a mean of 0.45 logs, increasing by

102 rovided genital exfoliated cell specimens at semiannual visits during a 2-year study.

103 Semiannual visits included questionnaires, chart reviews

104 ensities, risk behavior self-reported during semiannual visits was used to estimate a standardized cu

105 Across 439 subsequent semiannual visits, 88 women (63%) reported DAA initiatio

106 nce system had their scar status assessed at semiannual visits.

107 , and follow-up continued through 2000, with semiannual visits.

108 were followed-up from enrollment through 13 semiannual visits.

109 uter simulation program generated 14 interim semiannual visual fields under conditions of high, moder

110 Of these, 7169 examinations were semiannual with 94 recurrences detected and 1065 examina